Department of Nursing, Shanghai Proton and Heavy Ion Center, Fudan University Cancer Hospital, Shanghai Key Laboratory of Radiation Oncology (20dz2261000), Shanghai Engineering Research Center of Proton and Heavy Ion Radiation Therapy, Shanghai, China.
Support Care Cancer. 2023 Oct 16;31(12):630. doi: 10.1007/s00520-023-08085-8.
The study examined the growth trajectory of fear of progression(FOP) in nasopharyngeal carcinoma (NPC) patients. In addition, sociodemographic and clinical variables of each trajectory class were analyzed.
Two hundred sixteen NPC patients undergoing proton and heavy ion therapy were measured beginning (T0) and end of a 4-week proton and heavy ion therapy (T1), 3 months (T2) and 6 months (T3) after discharge. And data from the final 197 NPC patients were analyzed. NPC patients' FOP was investigated by the Fear of Progression Questionnaire-Short Form (FOP-Q-SF) form T0 to T3. SPSS and Mplus were used for statistical analysis. The LGMM was used to analyze the trajectory of FOP followed up over 6 months after proton and heavy ion therapy. The logistic regression was utilized to compare the differences in sociodemographic and clinical characteristics of patients in different trajectory groups of FOP.
One hundred ninety-seven NPC patients were analyzed. LGMM analysis showed that three-group trajectory solution was the best fitting (low-fear decline FOP (14.21%), the moderate-fear stable FOP(43.15%), and high-fear rising FOP (42.64%). Significant positive associations were found between age < 30 years (β = 3.399, p = 0.023), with or without children (β = 3.1, p = 0.002), primary/recurrence (β = -6.196, p < 0.001), diagnosis < 3 months (β = 4.435, p = 0.031), high school education (β = 2.98, p = 0.048), and high fear rising FOP. Patients who had moderate financial stress (β = 2.51, p = 0.041), with or without children (β = 1.564, p = 0.003), primary/recurrence (β = -2.578, p = 0.005), less than 30 radiotherapy times (β = 0.979, p = 0.046) tended to report significant moderate-fear stable FOP over time.
42.64% of the NPC patients showed high-fear rising FOP over the 6 months after treatment. Age 18-30 years, with or without children, relapsed, diagnosis < 3 months, and high school education and reporting being a pessimist predicts higher FOP scores. Early identification of age 18-30 years, with or without children, relapsed, diagnosis < 3 months, and high school education might help to identify populations experiencing long-term FOP. Clinical teams responsible to develop the target interventions for management of FCR in clinical practice.
研究考察了鼻咽癌(NPC)患者恐惧进展(FOP)的增长轨迹。此外,还分析了每个轨迹类别的社会人口学和临床变量。
216 名接受质子和重离子治疗的 NPC 患者在开始(T0)和质子和重离子治疗结束时(T1)、3 个月(T2)和 6 个月(T3)进行了测量出院后。并对最后 197 名 NPC 患者的数据进行了分析。NPC 患者的 FOP 通过 T0 至 T3 的恐惧进展问卷-短表(FOP-Q-SF)进行调查。使用 SPSS 和 Mplus 进行统计分析。LGMM 用于分析质子和重离子治疗后 6 个月以上 FOP 的轨迹。逻辑回归用于比较不同 FOP 轨迹组患者在社会人口学和临床特征方面的差异。
分析了 197 名 NPC 患者。LGMM 分析表明,三组轨迹解决方案是最佳拟合(低恐惧下降 FOP(14.21%)、中恐惧稳定 FOP(43.15%)和高恐惧上升 FOP(42.64%)。年龄<30 岁(β=3.399,p=0.023)、有或没有孩子(β=3.1,p=0.002)、原发性/复发性(β=-6.196,p<0.001)、诊断<3 个月(β=4.435,p=0.031)、高中学历(β=2.98,p=0.048)和高恐惧上升 FOP 与高恐惧上升 FOP 呈显著正相关。中度经济压力(β=2.51,p=0.041)、有或没有孩子(β=1.564,p=0.003)、原发性/复发性(β=-2.578,p=0.005)、少于 30 次放疗(β=0.979,p=0.046)的患者随着时间的推移往往会报告出显著的中度恐惧稳定 FOP。
治疗后 6 个月内,42.64%的 NPC 患者出现高恐惧上升 FOP。18-30 岁、有或没有孩子、复发、诊断<3 个月、高中学历和悲观预测更高的 FOP 评分。早期识别 18-30 岁、有或没有孩子、复发、诊断<3 个月和高中学历可能有助于识别长期经历 FOP 的人群。负责制定临床实践中 FCR 管理目标干预措施的临床团队。